Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Insulet Corporation (PODD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
242.71+0.34 (+0.14%)
At close: 04:00PM EST
242.71 0.00 (0.00%)
After hours: 05:39PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Slow Stochastic

Slow Stochastic

Previous Close242.37
Open240.69
Bid194.44 x 1200
Ask285.00 x 900
Day's Range235.76 - 243.05
52 Week Range218.28 - 324.81
Volume1,017,923
Avg. Volume420,031
Market Cap16.739B
Beta (5Y Monthly)0.66
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-28% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for PODD

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Insulet Corporation
    Analyst Report: Insulet CorporationInsulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 150,000 insulin-dependent diabetics are using it worldwide.
    Rating
    Fair Value
    Economic Moat
    2 months agoMorningstar
View more
All
News
Press Releases
Advertisement
Advertisement